<!DOCTYPE>
<html>
<head>
<meta charset="UTF-8">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"> 
<meta name="viewport" content="width=1024"> 
<meta name="viewport" content="initial-scale = 1.0, user-scalable = yes, maximum-scale = 2.0"> 
<meta name="apple-mobile-web-app-capable" content="yes"> 
<meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"> 
<meta name="format-detection" content="telephone=no">

<title>ACCP</title>
<link rel="stylesheet" type="text/css" href="css/style.css">
<link rel="stylesheet" type="text/css" href="css/bootstrap.min.css">
<script type="text/javascript" src="js/jquery.js"></script>

<script type="text/javascript">
$(document).ready(function() { 

});
</script> 

</head>

<body>

    <h1 class="main_title">Modules summary</h1>
    
    
    <div class="col-xs-12 col-sm-12 col-md-12 col-lg-12">
        <h3 class="red_title">Module 3</h3>
    </div>
    
    <div class="col-xs-12 col-sm-12 col-md-12 col-lg-12 ">
    <ul class="custom_list">
        <li><strong>•</strong> Goals of asthma treatment include: Preventing chronic and troublesome symptoms, maintaining (near-)
   normal pulmonary function and normal activity levels, preventing recurrent exacerbations of asthma, Providing  
   optimal pharmacotherapy with minimal or no adverse effects and meeting patients’ and families’ expectations.</li>
           
        <li><strong>•</strong> The pharmacological options for long-term treatment of asthma fall into the following three main categories:
   Controller medications, Reliever (rescue) medications and Add-on therapies.</li>
        
        <li><strong>•</strong> For the best outcomes, regular daily controller treatment should be initiated as soon as possible after the diagnosis
   of asthma is made.</li>
        
        <li><strong>•</strong> Recommended options for initial controller treatment in adults and adolescents differs with presenting symptoms.</li>
        
        <li><strong>•</strong> Once asthma treatment has been commenced as previous, ongoing treatment decisions are based on a cycle
   of assessment, adjustment of treatment, and review of the response.</li>
        
        <li><strong>•</strong>  In control-based asthma management, pharmacological and non-pharmacological treatment is adjusted in
   a continuous cycle that involves assessment, treatment and review.</li>
        
        <li><strong>•</strong>Stepwise approach to control symptoms and minimize future risk:
        
        	<ul>
            	<li> - Step 1 : As-needed reliever inhaler, Preferred option: as-needed inhaled short-acting beta2-agonist (SABA).</li>
                <li> - STEP 2 : Low dose controller medication plus as-needed reliever medication, Preferred option:<br>
   regular low dose ICS plus as-needed SABA.</li>
   				<li> - STEP 3 : One or two controllers plus as-needed reliever medication:
     Preferred option (adults/adolescents):<br> combination low dose ICS/LABA as maintenance treatment plus as-needed
     SABA OR combination low dose ICS/formoterol (budesonide or beclometasone) as both maintenance
     and reliever treatment.<br>Preferred option (children 6–11 years): Moderate dose ICS plus as-needed SABA Before considering a step up.
     The options   at this step differ depending on age. </li>
     			<li> - STEP 4 : Two or more controllers plus as-needed reliever medication:<br>- Preferred option (adults/adolescents): Combination low dose ICS/formoterol as maintenance and reliever treatment,<br>- OR Combination medium dose ICS/LABA plus as-needed SABA.</li>
     			<li> - STEP 5 : Higher level care and/or add-on treatment, Preferred option:  Referral for specialist investigation
      and consideration of add-on treatment.</li>
     
            </ul>
        </li>
        
       
    </ul>
    </div>

</body>
</html>
 